Mitrajaya (fundamental: 1.7; valuation:1.4)'s revenue was up 55.13% to RM161.59 million against RM104.17 million in 1QFY14.
In a filing to the local bourse, Mitrajaya said its construction division recorded a profit before tax (PBT) of RM13.02 million, up 88.81% from RM6.90 million last year. This accounted for 70% of the group's PBT.
Meanwhile, its South Africa investment increased 58.71% to RM2.51 million against RM1.58 million last year.
The group expects the financial performance for FY15 to be strong, with the construction division contributing a significant high revenue and PBT as works of its existing on-going projects progress well from the current outstanding order book of RM1.75 billion.
The property division will also potentially contribute higher turnover from its newly launched project Wangsa 9 Residency, which has a satisfactory take up for Phase 1 and Phase 2 launched July and November last year respectively, it added.
Its investment in South Africa is also expected to record significant growth in revenue and profit; unbilled sales currently stand at Rand 98.75 million (RM29.86 million) which will be recognised progressively by end of this year.
Separately, the board said is in the midst of identifying a purchaser for its 51% shareholdings in Optimax Eye Specialist Centre Sdn Bhd.
Mitrajaya's share closed 5 sen or 2.59% lower at RM1.88, giving it a market capitalisation of RM757.1 million.
MITRA (9571)
http://www.theedgemarkets.com
